chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional adverse event reported; Patient was administered an expired dose of MMRII; This spontaneous report has been received from a medical assistant concerning a 33-year-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant therapies were not reported.   On 18-JAN-2022, the patient was vaccinated with 1 dose of a Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) vaccine (exact dose, route of administration, anatomical location and vaccine scheme were not provided; lot number S035354 has been verified to be a valid lot number, expiration date was reported and established on 05-NOV-2021), as prophylaxis (expired product administered). The patient did not have any other adverse events.
On about 6/27/2022 or 6/28/2022, I experienced head congestion and a scratchy throat. I took a home antigen test and got a positive result on 6/30/2022. On 7/1/2022, I went to an urgent care clinic to be retested for confirmation, and I tested positive on the PCR test they gave me. I was visiting a relative at this point, and I self-isolated from the rest of my family until I tested negative on 7/5/2022. On the flight back home afterwards, I made it a point to mask; I had also worn a mask during the flight to my relative's home city. In October 2022, I began experiencing a buzzing noise in both ears. I didn't really pay attention until November 2022, though. I went to my PCP, who suggested that I undergo a hearing test and see a specialist. On 12/16/2022, I saw an otolaryngologist, who administered a hearing test. I had previously undergone a hearing test in September 2019, and it was then found that I had had some hearing loss. After the 12/16/2022 hearing test, the otolaryngologist concluded that my hearing had not deteriorated considerably since September 2019. The doctor confirmed that I had tinnitus. He couldn't offer a cure or a treatment, but he did tell me that another patient of his had tried taking lipo-flavonoid, and they had had decreased buzzing in the ears. I took lipo-flavonoid for three months, and there was no change. I've recently begun undergoing acupuncture therapy, because I have heard that it can sometimes help. However, in the six weeks I have received the treatments, I have noticed no change.
The person who administered the vaccine was not careful. She injected the vaccine way too high on my right arm, pretty much directly in my shoulder!! Also she didn't put the needle in at a 90 degree angle, but she had the needle facing downward when she injected the needle into my shoulder!! I have been in intense pain ever since she gave me the shot. I can't move my arm at all. I am extremely worried that I will have SIRVA.
Redness and Swelling at site of the immunization. There are distinct areas of redness around each injection site.
Nausea for 3 days, vomiting, body aches for 2 days, diarrhea
arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore at the injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm was sore at the injection site). At the time of the report, VACCINATION SITE PAIN (arm was sore at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-378927 (Patient Link).
Started breaking out with a measles rash which became quite significant and other than knowing that he had just had the vaccination, he looked like he had a terrible case of the measles which covered him head to toe and took over a week to go completely away and he ran a low grade fever.
2 Lesions under the tongue, swollen left armpit lymph node, earache.
I am a physician. I am fairly certain that I had myositis.  The day after my injection, I developed SEVERE muscle pain to the point I required assistance getting out of bed. It was mostly in the legs and arms. This lasted about 4 days. I am a regular runner. My endurance dramatically dropped (running 8 miles to being unable to run three miles without frequent stops. The second injection was similar, but I had more sever muscle pain and fever lasting about 1 week. My endurance took another dive. I developed muscle tremors whenever I held a contraction in my muscle. Even driving my car, my leg muscles would shake with my foot on the gas pedal for any length of time. This lasted about 3 months. My second shot was in January. It was not until July that I started to feel like my strength had returned.
The pt experienced testicular pain and swelling. No fever, no other symptoms. Slowly resolving over course of 10 days.
I experienced headaches, fatigue, loss of appetite, diarrhea, cough, memory loss and chest pains.
People got sick after receiving the booster dose; got COVID afterwards; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (People got sick after receiving the booster dose) and COVID-19 (got COVID afterwards) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (People got sick after receiving the booster dose) and COVID-19 (got COVID afterwards). At the time of the report, ILLNESS (People got sick after receiving the booster dose) and COVID-19 (got COVID afterwards) outcome was unknown.            No concomitant medications were provided. Reporter states that she knows some people who got sick after receiving the booster dose. No further details were provided. patient know several people that got the booster. They got COVID afterwards. No treatment medication was provided.  On 17-Nov-2022, the case ID MOD-2022-672866 was processed as invalid as it contains no patient identifiers.(multiple patients with no patient identifiers)   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2022: Significant follow-up received, updated Event and Narrative. On 18-Nov-2022: Non-significant follow-up received QE ID added.
Extreme Hives  8 days post Booster of Moderna  Hives unresponsive to creams and benadryl/Claritin Muscle and joint soreness along with hives Treatment: Zyrtec 2x a day Famotidine 2x a day Hydroxyzine 3x a day They have lessened but still present
This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Frequent urination), DIARRHOEA (Diarrhoea), LETHARGY (Lethargic), ASTHENIA (Weakness) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced POLLAKIURIA (Frequent urination), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). On 22-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), LETHARGY (Lethargic) and ASTHENIA (Weakness). At the time of the report, POLLAKIURIA (Frequent urination), DIARRHOEA (Diarrhoea), LETHARGY (Lethargic), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Heart rate: elevated (High) Patient had elevated heart rate..         Action taken with mRNA-1273 in response to the events was not applicable.  No concomitant medications were reported.  No treatment information was provided.
a little bit of arm pain/Her arm was a little amount sore; This is a spontaneous report from a contactable consumer. An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9262), via an unspecified route of administration on 01Feb2021 09:45 at a single dose for COVID-19 immunization. Medical history included ongoing Splenic marginal cell non-Hodgkin's Lymphoma of the B cells and spleen; infection in her bursae sack in her knee and she was in the hospital for that; she also had three infections. There were no concomitant medications. The patient reported that the shot was so simple, and she hates shots. It was the Pfizer shot given by a nurse at the clinic. Before bed on 01Feb2021, she thought her arm was starting to hurt so she took a pain pill. She doesn't think she needed it. She got the vaccine at 09:45 in the morning of 01Feb2021. She thought she had arm pain, but she didn't really ever get it. She didn't experience pain or anything otherwise. She also stated that she had a little bit of arm pain, her arm was a little amount sore. But it went away by the next day on 02Feb2021. It was very minor. She didn't feel like it was worth reporting. She felt it once in a while if she moves her arm but is not enough to mention. She hates shots, and this one wasn't as bad as half of the other shots she has had. She has no complaint about it. The outcome of the event was recovered on 02Feb2021.
Swollen arm, neck and face on left side. More pronounced 2 days after vaccine.  2 weeks later, still swollen, but not as noticeable.
On Jan. 8th I had significant shaking in my hands, arms and shoulders, lower legs about 20 mins after injection and lasted about an hr after that. Then is eased. then it began again about 12:30 pm and lasted until 5:30 PM roughly. Jan 9th i felt okay. On Jan 10, 11th, 12th it returned. Then after the 12th it eased, and there was spiritic shaking but not has intense and those three days. Then 16 days after i had the injection on jan 24th i woke up in the morning i developed sensitivity the left temple of my head close to my eye on the left side of my face. Kind of feels like slight bruising and numbing. And my left eye lid feels heavy. and my vision feels slightly affected. That has continued through today Jan 29 and has been on going since the 24th.
Patient received vaccine on 10/31/14 and 11/4/14 went to ER because the right side of her face twisted and was numb. Dx with Bell's Palsy started on steroids antivirals as of 11/6/14.
-Congestion-cough x 2 wks that lead to diagnosis of right lower lobe pneumonia. Treated with Amoxicillin.
1. sensation of spinning  when turn her head to quickly  within 5 minutes after receiving vaccine  2. migraine aura approximately 48 hours after vaccine (pt stated the migraine maybe from weather change)
he had a little soreness of the arm with first  dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Apr2021 (Batch/Lot number: unknown) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "he had a little soreness of the arm with first  dose".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On the night of May 7th, 2022 I experienced symptoms. Significant sore throat and severe headache. There was a lot of upper respiratory congestion, and still a little left in my chest. The next day I tested for COVID and it was positive. I was seen on a telehealth appointment on that Tuesday, May 10th. I was prescribed Paxlovid. My symptoms started to get better around May 21st. I wasn't so fatigued and the head congestion eased up. I felt like I was finally turning the corner. I still have lingering symptoms, a little fatigue and congestion in the center of my chest.
prior to vaccine, pt felt nauseous. they decided to get the vaccine even though we suggested to hold off. After administration, pt felt nauseous and fell asleep but was able to be wakened. we called 911. pt was evaluated by ems
redness and swelling at the injection site; swelling at the injection site; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of injection site erythema in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, 1 week after receiving Arexvy, the patient experienced injection site erythema (Verbatim: redness and swelling at the injection site) and injection site swelling (Verbatim: swelling at the injection site).  The outcome of the injection site erythema and injection site swelling were not reported.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Arexvy.     It was unknown if the company considered the injection site erythema and injection site swelling to be related to Arexvy.   Additional Information: GSK Receipt Date: 26-SEP-2023 It was reported that patient had redness and swelling at the injection site, the size of a silver dollar a week after the injection.
pt had redness irritation at injection site-- he left our inject safe barrier bandage on for 3 days also-- we generally recommend to take it off when pt gets home. He still has some redness to area but does not complain or pain or malaise
Inpatient for sacral fracture and is NWB BLEs; since receiving injection has been unable to use her right arm to move about in bed. She is unable to move her right arm without discomfort. She is unable to participate in OT/PT therapies as effectively as it is assumed she would be able to if not for the side-effect of injection.
Patient states she had a red, itchy rash at the site of administration, sore throat, & headache - symptoms lasted 3 days -  pt took Benadryl & symptoms subsided
Patient had what appeared to be a gran mal seizure that occurred without warning approximately 2 hrs after receiving the flu vaccine.  He has no prior hx of seizures, there is no family hx of seizures, and he otherwise has been in good health.  It's unclear if there is any relationship between the vaccination and the development of the seizure other than the timing.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because their facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger that caller was unable to download were for the months of Dec-2021, Jan-2022, and Feb-2022. It was also reported that no adverse reactions were reported by patient.  No treatment information was provided.   This case was linked to MOD-2022-501575 (Patient Link).
Information has been received from a registered nurse referring to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with improper stored RECOMBIVAX HB (dose, route and lot number not provided) for routine vaccination. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient vaccinated with J&J vaccine 3 weeks ago with 4.5 weakness and decreased mobility in the arm that he received vaccine in- cannot lift arm above shoulder .  No inflammation noted
Lightheaded, dizzy, nausea, severe body aches, headache, swollen lymph nodes on left side of neck, extreme fatigue
On 9/8/98, complained of rash, "blisters all over", on scalp, arms. Has pruritic papular lesions, which started on back and some on hand, arms and neck. Differential dx: insect bite. Hyperactive, no able to sit still at all. Chickenpox, probable post vax. Treat with Benadryl, Domeboro and Lotrimin.
Swelling, burning red ear on side of shot, nausea, headache, shortness of breath, stomachache, weakness.
experiences nauseous; threw up; headache; temperature of 102; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 12 year-old male patient received bnt162b2 (COMIRNATY), administration date 13Jan2022 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "ADHD" (unspecified if ongoing). Concomitant medication(s) included: METHYLPHENIDATE taken for attention deficit hyperactivity disorder; GUANFACINE taken for attention deficit hyperactivity disorder. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 14Jan2022, outcome "not recovered", described as "experiences nauseous"; VOMITING (non-serious) with onset 14Jan2022, outcome "unknown", described as "threw up"; HEADACHE (non-serious) with onset 14Jan2022, outcome "unknown", described as "headache"; PYREXIA (non-serious) with onset Jan2022, outcome "unknown", described as "temperature of 102". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Abnormal behavior immediately after receiving the vaccine.  Rash that looks like measles, red, with bumps.
Small knot felt at first by employee.  Employee states about 0.5in circle.  Throughout the day it had increased in size.  Her pain from the injection site has not gotten worse.  The knot on 9/29/2022 measured approximately 2in. in circumference.
administered 2 day after the expiry date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided Concomitant medications were not mentioned   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up information received on 23 JUN 2021 contains no significant information
Fussy, Crying, Screaming Fever, Rash, Swelling/Tightness at injection sight
Pt recv vax on 9/11/98; on 9/12/98 pt exp localized erythema, swelling &induration of LL at injection site.
Extremely tired the day after I had my shot.  I slept all day the next day and that night.  I woke up feeling fine the day after.
Information has been received from a registered nurse concerning a white patient with no medical history, who on 24-AUG-2007, at 1:00 p.m., was vaccinated into left arm with a second dose of GARDASIL (Lot# 658488/0930U). On 25-AUG-2007 the patient experienced facial stinging. It was reported that the patient felt better after going to a cool environment. On 27-AUG-2007 a rash erupted on the arms and hands and feet were swollen. The patient developed generalized erythema and a maculopapular rash. The patient underwent serum multiallergen radicallergosorbent, complete blood cell count and serum antinuclear antibodies (results not reported). At this reporting time the patient's outcome is unknown. Additional informtion is not expected.
he had the same experience with the tin taste after getting the COVID-19 Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TASTE DISORDER (non-serious) with onset 01Apr2021, outcome "unknown", described as "he had the same experience with the tin taste after getting the COVID-19 Vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.